MORRISTOWN, N.J., Feb. 18, 2025 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI) today announced the appointment of David Dornan, PhD as the Company's Chief Scientific Officer (CSO). Dr. Dornan ...
Hosted on MSN
Elevation Oncology announces CSO departure
Elevation Oncology , Inc. (NASDAQ:ELEV), a biotechnology firm specializing in biological products with a current market capitalization of $41 million, announced the upcoming departure of its Chief ...
David Dornan does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Elevation Oncology, Inc., and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results